Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 33 papers were listed this time. Here's a few in our areas of research interest:
Haim Erder M, Xie J, Signorovitch JE, et al. Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison. Appl Health Econ Health Policy. 2012 Nov 1;10(6):381-95. PubMed PMID: 23113551.
Bartsch SM, Curry SR, Harrison LH, et al. The potential economic value of screening hospital admissions for Clostridium difficile. Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3163-71. Epub 2012 Jun 30. PubMed PMID: 22752150.
Gajic-Veljanoski O, Bayoumi AM, Tomlinson G, et al. Vitamin K supplementation for the primary prevention of osteoporotic fractures: is it cost-effective and is future research warranted? Osteoporos Int. 2012 Nov;23(11):2681-92. Epub 2012 Mar 8. PubMed PMID: 22398856.
Lippuner K, Johansson H, Borgström F, et al. Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland. Osteoporos Int. 2012 Nov;23(11):2579-89. Epub 2012 Jan 6. PubMed PMID: 22222755.